NIH Scientists Issue ‘Bethesda Declaration’ to Protest Research Politicization

In an open letter, researchers and staff at the National Institutes of Health raise concerns over recent policy changes.

Written byShelby Bradford, PhD
| 2 min read
Photograph of a red brick building with white columns.
Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

On Monday, June 9, 2025, more than 300 current and former employees across the National Institutes of Health (NIH) signed and submitted a formal letter to Jay Bhattacharya, director of the NIH, outlining their concerns about several changes to research funding and staffing across the institution. The letter, called the Bethesda Declaration, was also sent to the Secretary of the Department of Health and Human Services, Robert F. Kennedy Jr., and members of Congress who serve on panels related to the NIH.

The Bethesda Declaration calls for an end to what NIH employees say is the politicization of research which wastes taxpayer money, threatens the well-being of clinical trial participants, and disregards the patients who donated biological samples to advance research. They highlighted the cancellation of more than 2,100 (and increasing) NIH grants and freezes on funding to universities as examples of political targeting. The letter also called attention to examples in which funding decisions for grants and applications appeared to be politically motivated, which they said “undermine peer review”. Additionally, they raised concerns about the stymying of scientific discovery because of halted global collaborations and terminations across the NIH.

The signers stated in that letter that their prior communications about these concerns had not been adequately heard and responded to. The Declaration states that while the above actions reduced NIH spending, these come at the expense of “life-saving research” with no improvement in efficiency.

Some people signed the letter anonymously while other NIH scientists and staff members signed with their names visible. So far, more than 6,000 people, many of whom are also scientists working beyond the NIH, have signed the letter after its release in support. Multiple researchers shared the letter on LinkedIn. Some indicated their personal reasons for signing the letter, which included supporting clinical trial participants and underserved communities affected by these policy changes. In a statement for the Associated Press, Jenna Norton, a program director at the National Institute of Diabetes and Digestive and Kidney Diseases, said, “I want people to know how bad things are at [the] NIH.”

The release of the Bethesda Declaration coincides with a hearing of the Senate Appropriation Committee's Subcommittee on Labor, Health and Human Services, Education, and Related Agencies on Tuesday, June 10, 2025. At the hearing, Bhattacharya testified on the federal budget proposed by the Trump Administration that reduces funding to the NIH by more than 40 percent. In response to the letter, some members of the House Committee on Energy and Commerce asked for a hearing with Bhattacharya regarding points made in the Bethesda Declaration.

Related Topics

Meet the Author

  • Shelby Bradford, PhD

    Shelby is an Assistant Editor at The Scientist. She earned her PhD in immunology and microbial pathogenesis from West Virginia University, where she studied neonatal responses to vaccination. She completed an AAAS Mass Media Fellowship at StateImpact Pennsylvania, and her writing has also appeared in Massive Science. Shelby participated in the 2023 flagship ComSciCon and volunteered with science outreach programs and Carnegie Science Center during graduate school. 

    View Full Profile
Share
You might also be interested in...
Loading Next Article...
You might also be interested in...
Loading Next Article...
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies

Parse Logo

Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas

Sino Biological Logo

Sino Biological's Launch of SwiftFluo® TR-FRET Kits Pioneers a New Era in High-Throughout Kinase Inhibitor Screening

SPT Labtech Logo

SPT Labtech enables automated Twist Bioscience NGS library preparation workflows on SPT's firefly platform